EX-10.2




 EXHIBIT 10.2 

INVESTOR RIGHTS AGREEMENT 

THIS INVESTOR RIGHTS AGREEMENT (this “Agreement”) is made as of January 4, 2013, by and among ECPM Holdings, LLC, a
Delaware limited liability company (the “Company”), Avraham Levy (“Levy”) and the Persons listed on the Schedule of Major Members attached hereto (each, a “Major Member” and collectively, the
“Major Members”). 
 WHEREAS, the Company and certain of the Major Members (each, an “Investor” and
collectively, the “Investors”) are parties to a Unit Purchase Agreement, dated as of October 6, 2012 (the “Purchase Agreement”), pursuant to which, among other things, the Investors shall purchase the
Company’s newly-authorized Class A Units (the “Class A Units”); 
 WHEREAS, in order to induce the Investors
to enter into the Purchase Agreement and consummate the transactions contemplated thereby, the Company has agreed to enter into this Agreement for the benefit of the Investors; 

WHEREAS, the execution and delivery of this Agreement is a condition to the Closing under the Purchase Agreement; and 

WHEREAS, unless otherwise provided in this Agreement, capitalized terms used herein shall have the meanings set forth in Section 2
hereof. 
 NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby agree as follows: 
 Section 1. Covenants. 

1A. Financial Statements and Other Information. The Company shall deliver to each Major Member and each Qualifying
Executive: 
 (i) within 30 days after the end of each monthly accounting period in each Fiscal Year, unaudited consolidated statements of
income or operations, stockholders’ equity (or the equivalent) and cash flows of the Company and its Subsidiaries on a combined basis for such monthly period and for the period from the beginning of the Fiscal Year to the end of such month, and
an unaudited consolidated balance sheet of the Company and its Subsidiaries on a combined basis as of the end of such month, setting forth for each monthly accounting period in each Fiscal Year comparisons to the Company’s annual budget and to
the corresponding period in the preceding Fiscal Year, and all such statements shall be prepared in accordance with GAAP, consistently applied; 

(ii) within 45 days after the end of each quarterly accounting period in each Fiscal Year, unaudited consolidated statements of income or
operations, stockholders’ equity (or the equivalent) and cash flows of the Company and its Subsidiaries on a combined basis for such quarterly period and for the period from the beginning of the Fiscal Year to the end of such quarter, and an
unaudited consolidated balance sheet of the Company and its Subsidiaries on a combined basis as of the end of such quarter, setting forth for each quarterly accounting period in each Fiscal Year comparisons to the Company’s annual budget and to
the corresponding period in the preceding Fiscal Year, and all such statements shall be prepared in accordance with GAAP, consistently applied; 

(iii) within 120 days after the end of each Fiscal Year, consolidated statements of income or operations, stockholders’ equity (or the
equivalent) and cash flows of the Company and its 








 
Subsidiaries on a combined basis for such Fiscal Year, and a consolidated balance sheet of the Company and its Subsidiaries on a combined basis as of the end of such Fiscal Year, setting forth in
each case comparisons to the Company’s annual budget and to the preceding Fiscal Year, all prepared in accordance with GAAP, consistently applied and accompanied by (a) an unqualified opinion of the Company’s accounting firm (selected
by the Company’s board of directors (the “Board”), but subject to the approval of the holders of a majority of the then issued and outstanding Class A Units (the “Investor Majority”) if such firm is not a
“Big Four” accounting firm) and (b) a copy of such firm’s annual management letter to the Company’s audit committee; 

(iv) promptly upon receipt thereof, any additional reports, management letters or other detailed information concerning significant aspects of
the Company’s or any of its Subsidiaries’ operations or financial affairs given to the Company or any of its Subsidiaries by their independent accountants (and not otherwise contained in other materials provided hereunder); 

(v) at least 15 days but no more than 60 days prior to the beginning of each Fiscal Year, an annual budget and operating plan prepared on a
quarterly basis for the Company and its Subsidiaries for such Fiscal Year (displaying anticipated statements of income and cash flows and balance sheets and approved by the Board), and (x) promptly upon preparation thereof any other significant
budgets or operating plans prepared by the Company and any revisions of such annual or other budgets or operating plans and (y) promptly upon any substantial adverse deviation from such annual budget in any month, a written report explaining
the extent and causes of such deviation and the actions proposed by the Company to be taken with respect thereto; 
 (vi) promptly after the
discovery or receipt of notice of any material noncompliance or default under any material agreement to which the Company or any of its Subsidiaries is a party or any material adverse change, event or circumstance affecting the Company or any of its
Subsidiaries (including the filing of any material litigation against the Company or any of its Subsidiaries or the existence of any known material dispute with any Person which involves a reasonable likelihood of such litigation being commenced), a
certificate specifying the nature and period of existence thereof and what actions the Company and/or its Subsidiaries have taken and propose to take with respect thereto; and 

(vii) with reasonable promptness, such other financial data and information (including regulatory/compliance information) concerning the
Company and its Subsidiaries as any Investor may reasonably request. 
 Each of the financial statements referred to in Sections 1A(i) and
1A(iii) shall present fairly in all material respects the financial condition and operating results of the Company and its Subsidiaries as and to the extent specified above as of the dates and for the periods set forth therein, subject in the
case of the unaudited financial statements to changes resulting from normal year-end audit adjustments for recurring accruals (none of which would, alone or in the aggregate, be materially adverse to the financial condition, operating results,
assets or operations of the Company and its Subsidiaries taken as a whole) and the absence of footnotes with respect thereto. Notwithstanding the foregoing, the provisions of this Section 1A and Section 1B shall cease to be
effective so long as the Company is subject to the periodic reporting requirements of the Securities Exchange Act and continues to comply with such requirements. Except as otherwise required by law or judicial order or decree or by any governmental
agency or authority, each Person entitled to receive information regarding the Company and its Subsidiaries under this Section 1A or Section 1B shall use the same standards and controls which such Person uses to maintain the
confidentiality of its own confidential information (but in no event less than reasonable care) to maintain the confidentiality of all nonpublic information of the Company and its Subsidiaries obtained by it pursuant to this Section 1A
or Section 1B below; provided that each such Person may disclose such information (a) to managers, partners, members, directors, officers, representatives and agents of such 

  
 2 









 
Person, (b) in connection with enforcing such Person’s rights under this Agreement and the other agreements contemplated hereby (including the Transaction Agreements), (c) as part
of such Person’s normal reporting, rating or review procedure (including normal credit rating and pricing process), or in connection with such Person’s or its Affiliates’ normal fundraising and related marketing, or informational or
reporting activities, or to such Person’s or its Affiliates’ auditors, accountants, attorneys or other agents, or (d) in connection with any proposed sale or transfer of Company equity securities if such Person’s transferee
agrees in writing to be bound by the confidentiality provisions hereof for the benefit of the Company. 
 1B. Certain Inspection
Rights. The Company shall permit any representatives designated by a Major Member or Qualifying Executive, upon reasonable notice, during normal business hours and in a manner that does not unreasonably interfere with the ordinary conduct of the
Company’s business, to (i) visit and inspect any of the properties of the Company and its Subsidiaries, (ii) examine the corporate, financial and other records of the Company and its Subsidiaries and make copies thereof or extracts
therefrom and (iii) consult with the directors, managers, officers, compliance personnel, key employees and independent accountants of the Company and its Subsidiaries concerning the affairs, compliance or regulatory status, finances and
accounts of the Company and its Subsidiaries. The presentation of an executed copy of this Agreement by any Qualifying Executive, Major Member or such other holder to the independent accountants of the Company or any of its Subsidiaries shall
constitute permission to its independent accountants to participate in discussions with such Investors or their respective officers, directors, managers, employees, agents or advisors. 

1C. Certain Affirmative Covenants. The Company shall, and shall cause each of its Subsidiaries to, unless it has received the prior
written consent of the Investor Majority, enforce the provisions of all agreements entered into between the Company or any of its Subsidiaries and any of their equityholders, managers, executive officers or key employees and exercise all of their
rights and remedies thereunder, including without limitation enforcement of the Transaction Agreements. 
 1D. Green Dot Prohibition.
The Company shall not enter into any banking or nonbanking transaction with Green Dot Corporation or any of its subsidiaries (e.g., Next Estate Communications and Bonneville Bancorp) without the prior written consent of the Sequoia Funds.

 Section 2. Definitions. For the purposes of this Agreement, the following terms have the meanings set forth below: 

“Affiliate” of any particular Person means any other Person controlling, controlled by or under common control with such
particular Person, where “control” means the possession, directly or indirectly, of the power to direct the management and policies of a Person whether through the ownership of voting securities, contract or otherwise. 

“Confidential Information” means all information of a confidential or proprietary nature, whether tangible or intangible, in
any form or medium provided, which is not generally known to the public, including (i) information that relates to the business, operations, strategies, prospects, structure or status of the Company or any of its Subsidiaries (whether
information was produced by the Company or any of its Subsidiaries), (ii) third party information which the Company or any of its Subsidiaries treats or is required to treat as confidential or proprietary, and (iii) hardware, software and
enhancements thereto, schematics and designs, know-how, techniques, systems, processes, trade secrets, customer and supplier data, pricing data, manuals and confidential documents and reports relating to the
business, operations, strategies, prospects, assets, structure or status of the Company or any of its Subsidiaries. 

“GAAP” means United States generally accepted accounting principles. 

  
 3 









 “Person” means an individual, a partnership, a corporation, a limited liability
company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization and a governmental entity or any department, agency or political subdivision thereof. 

“Qualifying Executive” means Levy, for so long as Levy continues to hold (i) Company equity securities representing a
Universal Percentage (as defined in the Restated LLC Agreement) in excess of 5% or (ii) Class C Units (as defined in the Restated LLC Agreement) in an amount greater than 60% of the Class C Units held thereby on the date hereof (as
equitably adjusted for equity splits, combinations, dividends and similar events). 
 “Restated LLC Agreement” means the
First Amended and Restated Limited Liability Company Agreement of the Company by and among the Company and its members, of even date herewith. 

“Securities Exchange Act” means the Securities Exchange Act of 1934, as amended, or any successor federal law then in force.

 Each capitalized term used but not defined herein shall have the meaning given to such term in the Restated LLC Agreement. 

Section 3. Miscellaneous. 
 3A.
Expenses. The Company shall pay, and hold each Investor and each of their Affiliates harmless against liability for the payment of, the out-of-pocket fees and expenses of such Persons (including the fees and expenses of legal counsel or other
third party advisors) arising in connection with (i) any completed or proposed acquisition, merger, initial public offering, sale or recapitalization or similar transaction involving the Company or any of its Subsidiaries, (ii) any
amendments or waivers (whether or not the same become effective) requested by the Company or its Members (other than the Investors) under or in respect of the Transaction Agreements (including in connection with any completed or proposed
acquisition, merger, sale or recapitalization or similar transaction by or involving the Company or any of its Subsidiaries), (iii) the interpretation, investigation and enforcement of the rights granted under the Transaction Agreements.
(iv) stamp and other taxes which may be payable in respect of the execution and delivery of this Agreement, the other Transaction Agreements or the agreements contemplated hereby or the issuance, delivery or acquisition of any Holdings LLC
equity securities, (v) the reasonable fees and expenses incurred by such Person in any filing with any governmental entity with respect to its investment in the Company or any of its Subsidiaries or in any other filing with any governmental
entity with respect to the Company or any of its Subsidiaries which mentions such Person, and (vi) all reasonable travel expenses, legal fees and other fees and expenses as have been or may be incurred in connection with any Company-related
financing or in connection with the rendering of any other services by such Person or its Affiliates to the Company and its Subsidiaries. 

3B. Remedies. Each holder of Class A Units shall have all rights and remedies set forth in this Agreement, the certificate of
formation, the Restated LLC Agreement and all rights and remedies which such holders have been granted at any time under any other agreement or contract and all of the rights which such holders have under applicable Law. Any Person having any rights
under any provision of this Agreement shall be entitled to enforce such rights specifically (without posting a bond or other security), to recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights
granted by Law. The parties hereto agree and acknowledge that money damages may not be an adequate remedy for any breach of the provisions of this Agreement and that, in addition to any other rights and remedies existing in its favor, any party
shall be entitled to specific performance and/or other injunctive relief from any court of law or equity of competent jurisdiction (without posting any bond or other security) in order to enforce or prevent violation of the provisions of this
Agreement. 

  
 4 









 3C. Amendments and Waivers. Except as otherwise expressly provided herein, no
modification, amendment or waiver of any provision of this Agreement shall be effective unless such modification, amendment or waiver is approved in writing by the Company and the Investor Majority. No other course of dealing between the Company or
any Investor or other Major Member or any delay in exercising any rights hereunder shall operate as a waiver of any rights of any such Persons. 

3D. Successors and Assigns. Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by
or on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors and permitted assigns of the parties hereto whether so expressed or not, and whether or not any express assignment has been made, the
provisions of this Agreement which are for any Major Member’s benefit as an Major Member, Investor or holder of Class A Units, Class B Units or Class C Units, as the case may be, or other Company equity securities are also for
the benefit of, and enforceable by, any subsequent holder of such Class A Units, Class B Units, or Class C Units, as the case may be, or other Company equity securities and may only be assigned in connection with, and in proportion
to, the transfer of such Class A Units, Class B Units, or Class C Units, as the case may be or Company equity securities. 

3E. Generally Accepted Accounting Principles. Where any accounting determination or calculation is required to be made under this
Agreement, such determination or calculation (unless otherwise provided) shall be made in accordance with GAAP, consistently applied, except that if because of a change in generally accepted accounting principles the Company would have to alter a
previously utilized accounting method or policy in order to remain in compliance with GAAP, such determination or calculation shall continue to be made in accordance with the Company’s previous accounting methods and policies, unless otherwise
directed by the Company’s audit committee or its independent auditors. 
 3F. Severability. Whenever possible, each provision of
this Agreement shall be interpreted in such manner as to be effective and valid under applicable Law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable Law, such provision shall be ineffective only to the
extent of such prohibition or invalidity, without invalidating the remainder of this Agreement. 
 3G. Counterparts. This Agreement
may be executed simultaneously in two or more counterparts, any one of which need not contain the signatures of more than one party, but all such counterparts taken together shall constitute one and the same Agreement. 

3H. Descriptive Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only and do not
constitute a substantive part of this Agreement. The use of the word “including” in this Agreement shall mean “including without limitation”. 

3I. Governing Law. All issues and questions concerning the construction, validity, enforcement and interpretation of this
Agreement and the exhibits and schedules hereto shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any choice of law or conflict of laws rules or provisions (whether of the State of
Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. 

3J. Notices. All notices, demands or other communications to be given or delivered under or by reason of the provisions of this
Agreement shall be in writing and shall be deemed to have been given when delivered personally to the recipient, sent to the recipient by reputable overnight courier service 

  
 5 









 
(charges prepaid) or mailed to the recipient by certified or registered mail, return receipt requested and postage prepaid. Such notices, demands and other communications shall be sent to each
Investor at the address indicated on the Schedule of Investors attached hereto (or, if not so indicated, to any such address indicated by the Company’s records) and to the Company at the address indicated below: 

 

			
	Notices to the Company:
	
	ECPM Holdings, LLC
	11810 Wills Road, Suite 100
	Alpharetta, Georgia 30009
	Attention:	  	Board of Directors
	Facsimile:	  	(866) 567-8218
	
	with a copy (which shall not constitute notice) to:
	
	Kirkland & Ellis LLP
	950 Page Mill Road
	Palo Alto, CA 94304
	Attention:	  	Adam D. Phillips
	Facsimile:	  	(650) 859-7500

 or to such other address or to the attention of such other person as the recipient party has specified by prior written notice
to the sending party. 
 3K. No Strict Construction. The parties hereto have participated jointly in the negotiation and drafting of
this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any
party by virtue of the authorship of any of the provisions of this Agreement. The parties hereto intend that each covenant and agreement contained herein shall have independent significance. If any party has breached any covenant or agreement
contained herein in any respect, the fact that there exists another covenant or agreement relating to the same subject matter (regardless of the relative levels of specificity) which such party has not breached shall not detract from or mitigate the
fact that such party is in breach of the first covenant or agreement. 
 3L. Third-Party Beneficiaries. The parties
hereto acknowledge and agree that all rights and privileges (including approvals and consents and rights to provide or withhold approval or consent) that may be exercised hereunder by the Investors or any group of Investors may be exercised by and
for the benefit of the Investors or such group of Investors may be exercised by the Sequoia Capital family of investment funds, general partner entities, and related entities (collectively, the “Sequoia Funds”) and for their own
accounts to the same extent as if such Sequoia Funds were parties hereto (unless otherwise agreed by each such Sequoia Fund). Notwithstanding anything to the contrary in this Agreement, this Section 3L may not be amended or modified
without the prior written consent of Sequoia Capital. 
 3M. Complete Agreement. This Agreement and the other agreements and
instruments referred to herein contain the complete agreement between the parties hereto with respect to the subject matter hereof and thereof and supersede any prior understandings, agreements and representations by or between the parties hereto
(whether written or oral) which may have related to the subject matter hereof or thereof in any way. 

  
 6 









 3N. Termination. Except for this Section 3, this Agreement will terminate upon
the closing of (i) a Liquidity Event, or (ii) with respect to each Major Member, at such time as such Major Member ceases to hold Company equity securities. 

3O. Investment Opportunities and Conflict of Interest. The Company acknowledges that the Investors along with certain of the other
Major Members (collectively, the “Institutional Members”) and their respective Affiliates, members, equity holders, director representatives, partners, employees, agents and other related persons are engaged in the business of
investing in private and public companies in a wide range of industries, including the industry segment in which the Company operates. Accordingly, the Company hereby expressly acknowledges and agrees that (i) the Institutional Members and
their Affiliates are permitted to have, and may presently or in the future have, investments or other business relationships with entities engaged in the business of the Company and its Subsidiaries other than through the Company or any of its
Subsidiaries (each, an “Other Business”), (ii) the Institutional Members have and may develop a strategic relationship with businesses that are and may be competitive or complementary with the Company or any of its
Subsidiaries, (iii) none of the Institutional Members will be prohibited by virtue of their investment in the Company or their service on the Company’s or its Subsidiaries’ Board from pursuing and engaging in any activities with an
Other Business or serving such Other Business in any capacity (as an officer, director or otherwise), (iv) none of the Institutional Members will be obligated to inform or present the Company or its Subsidiaries or the Board of any such
opportunity, relationship or investment, (v) none of the other members of the Company, including the other Institutional Members (the “Other Members”), will acquire or be entitled to any interest or participation in any Other
Business as a result of the participation therein of any of the Institutional Members, and (vi) the involvement of the Institutional Members in any Other Business will not constitute a conflict of interest by the Institutional Members with
respect to the Company or its members or any of the Company’s Subsidiaries. In furtherance of the foregoing, except as set forth in Section 1A, to the fullest extent permitted by Law, the Institutional Members shall have no
obligation of confidentiality or other duty to the Company or its Subsidiaries to refrain from using any information (other than Confidential Information) that comes into such Institutional Members’ possession as a result of such Institutional
Members’ investment in the Company, whether as a director, stockholder or otherwise, including, but not limited to, market trend and market data (the “Information Waiver”); provided, however, that the Information
Waiver shall not apply, and therefore such Investor shall be subject to such obligations and duties as would otherwise apply to such Institutional Member under applicable Law, if the information at issue (x) constitutes Confidential Information
or (y) is covered by a contractual obligation of confidentiality to which the Company or such Institutional Member is subject. Notwithstanding anything in this Section 3O to the contrary, nothing herein shall be (or be construed as)
a waiver of any Institutional Member’s duty of loyalty or obligation of confidentiality with respect to the disclosure of confidential information of the Company. 

*            *           
 *            *            * 

  
 7 









 IN WITNESS WHEREOF, the parties hereto have executed or caused to be executed on their behalf
this Investor Rights Agreement on the date first written above. 
  

			
	THE COMPANY:
	
	ECPM HOLDINGS, LLC
		
	By:		 /s/ Mark G. Gilreath

	Name:		 Mark G. Gilreath

	Its:		 CEO











 IN WITNESS WHEREOF, the parties hereto have executed or caused to be executed on their behalf
this Investor Rights Agreement on the date first written above. 
  

			
	THE INVESTORS:
	
	SC US GF V HOLDINGS, LTD.,
			a Cayman Islands exempted company
		
	By:		 Sequoia Capital U.S. Growth Fund V, L.P. and Sequoia Capital USGF Principals Fund V, L.P.,
both Cayman Islands exempted limited partnerships, its
 Members

		
	By:		 SCGF V Management, L.P.,
 a Cayman Islands
exempted limited partnership, its General Partner

		
	By:		 SC GF TT LTD.,
 a Cayman Islands exempted
company, its General Partner

		
	By:		 /s/ Scott Carter

		
	Name:		 Scott Carter

		
	Its:		Director
	
	SEQUOIA CAPITAL ISRAEL IV HOLDINGS, L.P.,
			a Cayman Islands exempted limited partnership
		
	By:		 SC ISRAEL IV MANAGEMENT, L.P., a Cayman Islands exempted limited partnership, its

General Partner

		
	By:		 SC Israel IV GenPar Ltd.,
 a Cayman Islands
company, its General Partner

		
	By:		 /s/ Shmuel Levy

		
	Name:  		 Shmuel Levy

		
	Its:		Managing Director


 [Signature Page to Investor Rights Agreement] 








 IN WITNESS WHEREOF, the parties hereto have executed or caused to be executed on their behalf
this Investor Rights Agreement on the date first written above. 
  

			
	THE OTHER MAJOR MEMBERS:
	
	RIVER CITIES CAPITAL FUND IV L.P.
	By:		River Cities Management IV LLC, its General Partner
		
	By:		 /s/ Edward C. McCarthy

	Name:		 Edward C. McCarthy

	Title:		 Manager

	
	RIVER CITIES CAPITAL FUND IV (N.Q.P.) L.P.
	By:		River Cities Management IV LLC, its General Partner
		
	By:		 /s/ Edward C. McCarthy

	Name:		 Edward C. McCarthy

	Title:		 Manager

	
	RCCF ENDOCHOICE, LLC
	By:		River Cities Management IV LLC, its Manager
		
	By:		 /s/ Edward C. McCarthy

	Name:  		 Edward C. McCarthy

	Title:		 Manager

	
	FIFTH THIRD CAPITAL HOLDINGS, LLC
		
	By:		 /s/ Vanessa Indriolo Vreeland

	Name:		Vanessa Indriolo Vreeland
	Title:		Senior Vice President, Private Equity


 [Signature Page to Investor Rights Agreement] 








 IN WITNESS WHEREOF, the parties hereto have executed or caused to be executed on their behalf
this Investor Rights Agreement on the date first written above. 
  

			
	THE OTHER MAJOR MEMBERS:
	
	COUNCIL CAPITAL II, LP
	By:		Council Capital Partners II, LLC, its General Partner
		
	By:		 /s/ Grant Jackson

	Name:		 Grant Jackson

	Title:		 General Partner

	
	ENVEST III, LLC
	By:		Envest Management III, LLC, its Managing Member
		
	By:		 /s/ David Kaufman

	Name:  		 David Kaufman

	Title:		 Manager

	
	MORGAN CREEK VENTURE PARTNERS ACCESS FUND LP
	By:		Morgan Creek Partners Venture, LLC, its General Partner
		
	By:		 /s/ Mark W. Yusko

	Name:		 Mark W. Yusko

	Title:		 CEO/CIO



 [Signature Page to Investor Rights Agreement] 








 IN WITNESS WHEREOF, the parties hereto have executed or caused to be executed on their behalf
this Investor Rights Agreement on the date first written above. 
  

			
	THE OTHER MAJOR MEMBERS:
	
	EVERGREEN V, L.P.
	By:		Evergreen V GP, L.P, its general partner
	By:		Evergreen 5 G.P. Ltd., its general partner
		
	By:		 /s/ Ronit Bendori

	Name:		 Ronit Bendori

	Title:		 Partner

	
	EVERGREEN V-A, L.P.
	By:		Evergreen V GP, L.P, its general partner
	By:		Evergreen 5 G.P. Ltd., its general partner
		
	By:		 /s/ Ronit Bendori

	Name:		 Ronit Bendori

	Title:		 Partner

	
	 U.M. ACCELMED L.P.,
 an Israeli
limited liability partnership

	 By: U.M. Accelmed Management (2009) Ltd.,

an Israeli limited liability company, its General Partner

		
	By:		 /s/ Uri Geiger

	Name:		Uri Geiger
	Title:		Its Director


 [Signature Page to Investor Rights Agreement] 








 IN WITNESS WHEREOF, the parties hereto have executed or caused to be executed on their behalf
this Investor Rights Agreement on the date first written above. 
  

	
	THE OTHER MAJOR MEMBERS:
	
	 /s/ Avraham Levy

	Avraham Levy


 [Signature Page to Investor Rights Agreement] 








 SCHEDULE OF MAJOR MEMBERS 

SC US GF V Holdings, Ltd. 
 Sequoia Capital Israel IV Holdings,
L.P. 
 In the case of each of the foregoing, with notices and other communications directed as follows: 

c/o Sequoia Capital 
 3000 Sand
Hill Road 
 Building 4, Suite 250 

Menlo Park, CA 94025 

Attention:        Scott Carter 

Fax:                 (650)
854-2977 
 with a copy (which shall not constitute notice) to: 

Kirkland & Ellis LLP 

950 Page Mill Road 
 Palo Alto, CA
94304 
 Attention:        Adam D. Phillips 

Fax:                 (650) 859-7500 

River Cities Capital Fund IV, L.P. 
 River Cities Capital Fund IV
(N.Q.P.), L.P. 
 RCCF EndoChoice, LLC 
 In the
case of each of the foregoing, with notices and other communications directed as follows: 
 3737 Glenwood Ave, 

Suite 100 
 Raleigh, NC 27612 

Attn: Rik Vandevenne 
 Fax:
(919) 573 6050 
 with a copy (which shall not constitute notice) to: 

Robinson Bradshaw & Hinson 

1450 Raleigh Road, Suite 100 

Chapel Hill, NC 27517 
 Attention:
John M. Fogg 
 Fax: 919.328.8796 
 Fifth Third
Capital Holdings, LLC 
 c/o Fifth Third Bank 

38 Fountain Square Plaza, 4th Plaza 

Cincinnati, OH 45202 
 Attention:
Scott J. Heberlein 
 Fax: 








 Council Capital II, LP 

150 Second Avenue North, Suite 415 

Nashville, TN 37201 

Attention: Grant A. Jackson 
 Fax:
(615) 255 3709 
 with a copy (which shall not constitute notice) to: 

Robinson Bradshaw & Hinson 

1450 Raleigh Road, Suite 100 

Chapel Hill, NC 27517 
 Attention:
John M. Fogg 
 Fax: 919.328.8796 
 Envest III,
LLC 
 2101 Parks Avenue, Suite 401 

Virginia Beach, VA 23451 
 Attn:
David Kaufman 
 Fax: (757) 437-3884 

with a copy (which shall not constitute notice) to: 

Robinson Bradshaw & Hinson 

1450 Raleigh Road, Suite 100 

Chapel Hill, NC 27517 
 Attention:
John M. Fogg 
 Fax: 919.328.8796 
 Morgan
Creek Venture Partners Access Fund LP 
 301 W. Barbee Chapel Road, Suite 200

Chapel Hill, NC 27517 
 Attn:

 Fax: 
 U.M. Accelmed, L.P. 

Life Plaza, 6 Ha’Hoshlim St., 

Herzliya Pituach 46120, Israel 

Fax: +972-9-9588594 
 Attention:
Dr. Uri Geiger 
 with a copy (that will not constitute notice) to: 

Agmon & Co., Rosenberg, Hacohen & Co. 

Electra Towers, 98 Yigal Alon St., 

Tel Aviv 67891, Israel 
 Fax:
+972-3-7666567 
 Attn: Jonathan Schwartz, Adv. 








 Evergreen V, L.P. 

Evergreen V-A, L.P. 
 In the case of each of the
foregoing, with notices and other communications directed as follows: 
 25 Habarzel St., Tel Aviv 69710 Israel 

Fax: +(972) 03-710-8210 

Attention: Ronit Bendori, Partner 

with a copy (which shall not constitute notice) to: 

Matry, Meiri & Co., Law Offices 

Gibor Sport Building, 24th floor 

7 Menachem Begin Street, 
 Ramat
Gan 52681, Israel 
 Fax +(972)-3-610-9009 

Attention: Keren Wacht, Adv 
 Avraham Levy